News
-
-
-
COMMUNIQUÉ DE PRESSE
Harvard Eye Associates Now Offering iDose(R) TR as a New Treatment Option to Reduce Eye Pressure in Patients With Ocular Hypertension and Open-Angle Glaucoma
Harvard Eye Associates introduces iDose® TR, a new FDA-approved treatment for glaucoma and ocular hypertension that provides long-duration drug therapy inside the eye. Dr. Teymoorian leads inaugural treatments at Alicia Surgery Center
